Tag: Andy Schmeltz

Pfizer lung cancer drug Lorbrena bags US FDA approval

pharmanewsdaily- November 3, 2018

Lorbrena FDA approval : US pharma giant Pfizer has bagged approval from the US Food and Drug Administration (FDA) for Lorbrena (lorlatinib) for anaplastic lymphoma ... Read More

Astellas, Pfizer score Xtandi FDA approval for non-metastatic CRPC

pharmanewsdaily- July 14, 2018

Xtandi FDA approval : Astellas Pharma and Pfizer said that the US Food and Drug Administration (FDA) has expanded the approval of cancer drug Xtandi ... Read More